Atsushi Mizokami

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 46

Top Venues

Cancers

The Prostate

International journal of urology : official journal of the Japanese Urological Association

Biomedicines

Kanazawa University

Kanazawa University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kanazawa University

Japan

Professor :: Department of Integrative Cancer Therapy and Urology

Education History

Kanazawa University Apr 01 2000

Japan

PHD :: Integrative Cancer Therapy and Urology

Publications

Shuhei Kamada, Shinichi Sakamoto, Ryo Kinoshita, Xue Zhao, Tomohiko Kamasako, Ryosuke Yamase, Junryo Rii, Shinpei Saito, Pae Sangjon, Akinori Takei, Yasutaka Yamada, Yusuke Goto, Yusuke Imamura, Taro Iguchi, Atsushi Mizokami, Hiroyoshi Suzuki, Koichiro Akakura, Tomohiko Ichikawa
Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix. The Prostate 84 (7) (2024)
Nobumichi Tanaka, Kouji Izumi, Yasushi Nakai, Takashi Shima, Yuki Kato, Koji Mita, Manabu Kamiyama, Shogo Inoue, Seiji Hoshi, Takehiko Okamura, Yuko Yoshio, Hideki Enokida, Ippei Chikazawa, Noriyasu Kawai, Kohei Hashimoto, Takashi Fukagai, Kazuyoshi Shigehara, Shizuko Takahara, Atsushi Mizokami
Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCa. The Prostate (2024)
Taketo Kawai, Hideyasu Matsuyama, Keita Kobayashi, Atsushi Ikeda, Makito Miyake, Nishimoto Koshiro, Yuto Matsushita, Hiroyuki Nishiyama, Kiyohide Fujimoto, Masafumi Oyama, Hideaki Miyake, Haruhito Azuma, Keiji Inoue, Takahiko Mitsui, Mutsushi Kawakita, Chikara Oyama, Atsushi Mizokami, Takashige Abe, Hajime Kuroiwa, Haruki Kume
Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study). International journal of urology : official journal of the Japanese Urological Association 31 (8) (2024)
Yuki Kato, Aya Kamatani, Kazuyoshi Shigehara, Atsushi Mizokami
Real-world short-term outcomes of prostate urethral lift in Japan: A prospective cohort study. International journal of urology : official journal of the Japanese Urological Association (2024)
Taketo Kawai, Hideyasu Matsuyama, Keita Kobayashi, Atsushi Ikeda, Makito Miyake, Nishimoto Koshiro, Yuto Matsushita, Hiroyuki Nishiyama, Kiyohide Fujimoto, Masafumi Oyama, Hideaki Miyake, Haruhito Azuma, Keiji Inoue, Takahiko Mitsui, Mutsushi Kawakita, Chikara Oyama, Atsushi Mizokami, Takashige Abe, Hajime Kuroiwa, Haruki Kume
Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study). International journal of urology : official journal of the Japanese Urological Association (2024)
Shuhei Kamada, Shinichi Sakamoto, Ryo Kinoshita, Xue Zhao, Tomohiko Kamasako, Ryosuke Yamase, Junryo Rii, Shinpei Saito, Pae Sangjon, Akinori Takei, Yasutaka Yamada, Yusuke Goto, Yusuke Imamura, Taro Iguchi, Atsushi Mizokami, Hiroyoshi Suzuki, Koichiro Akakura, Tomohiko Ichikawa
Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix. The Prostate (2024)
Shuhei Kamada, Shinichi Sakamoto, Ryo Kinoshita, Xue Zhao, Tomohiko Kamasako, Ryosuke Yamase, Junryo Rii, Shinpei Saito, Pae Sangjon, Akinori Takei, Yasutaka Yamada, Yusuke Goto, Yusuke Imamura, Taro Iguchi, Atsushi Mizokami, Hiroyoshi Suzuki, Koichiro Akakura, Tomohiko Ichikawa
Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix. The Prostate 84 (7) (2024)
Momokazu Gotoh, Kouji Izumi, Akihiro Goriki, Ryo Tasaka, Tomoya Hatayama, Takashi Shima, Yuki Kato, Manabu Kamiyama, Shogo Inoue, Nobumichi Tanaka, Seiji Hoshi, Takehiko Okamura, Yuko Yoshio, Hideki Enokida, Ippei Chikazawa, Noriyasu Kawai, Kohei Hashimoto, Takashi Fukagai, Kazuyoshi Shigehara, Shizuko Takahara, Yoshifumi Kadono, Atsushi Mizokami
Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa. Cancers 16 (3) (2024)
Yuki Kato, Aya Kamatani, Kazuyoshi Shigehara, Atsushi Mizokami
Real-world short-term outcomes of prostate urethral lift in Japan: A prospective cohort study. International journal of urology : official journal of the Japanese Urological Association 31 (8) (2024)
Taketo Kawai, Hideyasu Matsuyama, Keita Kobayashi, Atsushi Ikeda, Makito Miyake, Nishimoto Koshiro, Yuto Matsushita, Hiroyuki Nishiyama, Kiyohide Fujimoto, Masafumi Oyama, Hideaki Miyake, Haruhito Azuma, Keiji Inoue, Takahiko Mitsui, Mutsushi Kawakita, Chikara Oyama, Atsushi Mizokami, Takashige Abe, Hajime Kuroiwa, Haruki Kume
Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study). International journal of urology : official journal of the Japanese Urological Association 31 (8) (2024)
Momokazu Gotoh, Kouji Izumi, Akihiro Goriki, Ryo Tasaka, Tomoya Hatayama, Takashi Shima, Yuki Kato, Manabu Kamiyama, Shogo Inoue, Nobumichi Tanaka, Seiji Hoshi, Takehiko Okamura, Yuko Yoshio, Hideki Enokida, Ippei Chikazawa, Noriyasu Kawai, Kohei Hashimoto, Takashi Fukagai, Kazuyoshi Shigehara, Shizuko Takahara, Yoshifumi Kadono, Atsushi Mizokami
Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa. Cancers 16 (3) (2024)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Yoshifumi Kadono, Atsushi Mizokami
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (2) (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Yoshifumi Kadono, Atsushi Mizokami
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (2) (2023)
Yoshifumi Kadono, Takahiro Nohara, Shohei Kawaguchi, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Masashi Iijima, Kazuyoshi Shigehara, Kouji Izumi, Atsushi Mizokami
Postoperative functional and cancer control evaluation of conventional and Retzius-sparing robot-assisted radical prostatectomy: Comparison of selected cases by propensity score matching. The Prostate (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Yoshifumi Kadono, Atsushi Mizokami
Comparison of the Prognostic Value of Inflammatory and Nutritional Indices in Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (2) (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Atsushi Mizokami
Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (6) (2023)
Yoshifumi Kadono, Hiroyuki Konaka, Takahiro Nohara, Kouji Izumi, Satoshi Anai, Kiyohide Fujimoto, Tomoyuki Koguchi, Kei Ishibashi, Noriyasu Kawai, Keita Nakane, Akinori Iba, Naoya Masumori, Shizuko Takahara, Atsushi Mizokami
Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study. Cancers 15 (10) (2023)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Suguru Kadomoto, Atsushi Mizokami
Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma. Biomedicines 11 (6) (2023)
Hisamitsu Ide, Yuko Akehi, Shinichiro Fukuhara, Shin Ohira, Sumito Ogawa, Tomoya Kataoka, Hiroshi Kumagai, Ko Kobayashi, Akira Komiya, Kazuyoshi Shigehara, Takahiro Syuto, Jintetu Soh, Makito Tanabe, Hisanori Taniguchi, Koji Chiba, Kazuhito Matsushita, Yozo Mitsui, Takahiro Yoneyama, Tomoya Shirakawa, Yasuhisa Fujii, Hiroaki Kumano, Hajime Ueshiba, Toshiyasu Amano, Haruaki Sasaki, Seiji Maeda, Atsushi Mizokami, Kazuhiro Suzuki, Shigeo Horie
Summary of the clinical practice manual for late-onset hypogonadism. International journal of urology : official journal of the Japanese Urological Association (2023)
Tomomi Nakagawa, Kazuyoshi Shigehara, Yuki Kato, Shohei Kawaguchi, Hiroki Nakata, Taito Nakano, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples. Journal of medical virology (2022)
Ryunosuke Nakagawa, Kouji Izumi, Renato Naito, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kotaro Yoshida, Yoshifumi Kadono, Atsushi Mizokami
Does Bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT? Cancers 14 (23) (2022)
Kazuyoshi Shigehara, Yuki Kato, Kouji Izumi, Atsushi Mizokami
Relationship between Testosterone and Sarcopenia in Older-Adult Men: A Narrative Review. Journal of clinical medicine 11 (20) (2022)
Keita Kobayashi, Hideyasu Matsuyama, Taketo Kawai, Atsushi Ikeda, Makito Miyake, Nishimoto Koshiro, Yuto Matsushita, Kazumasa Komura, Takashige Abe, Haruki Kume, Hiroyuki Nishiyama, Kiyohide Fujimoto, Masafumi Oyama, Hideaki Miyake, Keiji Inoue, Takahiko Mitsui, Mutsushi Kawakita, Chikara Ohyama, Atsushi Mizokami, Hajime Kuroiwa
Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study). International journal of urology : official journal of the Japanese Urological Association 29 (7) (2022)
Tomoyuki Makino, Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
Epidemiology and Prevention of Renal Cell Carcinoma. Cancers 14 (16) (2022)
Hiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, Ren Toriumi, Shuhei Aoyama, Taiki Kamijima, Takafumi Shimada, Hiroshi Kano, Tomoyuki Makino, Renato Naito, Suguru Kadomoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami
Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer. Biomedicines 10 (10) (2022)
Hiroaki Iwamoto, Kouji Izumi, Tomoyuki Makino, Atsushi Mizokami
Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer. Cancers 14 (7) (2022)
Ryunosuke Nakagawa, Hiroaki Iwamoto, Tomoyuki Makino, Renato Naito, Suguru Kadomoto, Norihito Akatani, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kouji Izumi, Yoshifumi Kadono, Atsushi Takamatsu, Kotaro Yoshida, Atsushi Mizokami
Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men. Cancers 14 (19) (2022)
Yoshifumi Kadono, Takahiro Nohara, Shohei Kawaguchi, Hiroaki Iwamoto, Hiroshi Yaegashi, Kazuyoshi Shigehara, Kouji Izumi, Atsushi Mizokami
Impact of Pelvic Anatomical Changes Caused by Radical Prostatectomy. Cancers 14 (13) (2022)
Ryunosuke Nakagawa, Kouji Izumi, Renato Naito, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kotaro Yoshida, Yoshifumi Kadono, Atsushi Mizokami
Does Bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT? Cancers 14 (23) (2022)
Ryunosuke Nakagawa, Kouji Izumi, Renato Naito, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kotaro Yoshida, Yoshifumi Kadono, Atsushi Mizokami
Does Bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT? Cancers 14 (23) (2022)
Ryunosuke Nakagawa, Kouji Izumi, Renato Naito, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Shohei Kawaguchi, Takahiro Nohara, Kazuyoshi Shigehara, Kotaro Yoshida, Yoshifumi Kadono, Atsushi Mizokami
Does Bladder Cancer with Inchworm Sign Indicate Better Prognosis after TURBT? Cancers 14 (23) (2022)
Hiroaki Iwamoto, Kouji Izumi, Atsushi Mizokami
Editorial Comment to Omitting routine cystography after RARP: Analysis of complications and readmission rates in suprapubic and transurethral drained patients. International journal of urology : official journal of the Japanese Urological Association (2022)
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
Macrophage Polarity and Disease Control. International journal of molecular sciences 23 (1) (2021)
Tomoyuki Makino, Kouji Izumi, Atsushi Mizokami
Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment. Biomedicines 9 (4) (2021)
Kazuyoshi Shigehara, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Testosterone and Bone Health in Men: A Narrative Review. Journal of clinical medicine 10 (3) (2021)
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment. International journal of molecular sciences 22 (16) (2021)
Tomoyuki Makino, Kouji Izumi, Hiroaki Iwamoto, Atsushi Mizokami
Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer. Cancers 13 (17) (2021)
Renato Naito, Hiroshi Kano, Takashi Shimada, Tomoyuki Makino, Suguru Kadomoto, Hiroaki Iwamoto, Hiroshi Yaegashi, Kouji Izumi, Yoshifumi Kadono, Hiroki Nakata, Yohei Saito, Masuo Goto, Kyoko Nakagawa-Goto, Atsushi Mizokami
A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells. The Prostate 81 (5) (2021)
Yohei Saito, Atsushi Mizokami, Kouji Izumi, Renato Naito, Masuo Goto, Kyoko Nakagawa Goto
α-Trifluoromethyl Chalcones as Potent Anticancer Agents for Androgen Receptor-Independent Prostate Cancer. Molecules (Basel, Switzerland) 26 (9) (2021)
Yuki Kato, Kazuyoshi Shigehara, Shohei Kawaguchi, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Efficacy of testosterone replacement therapy on pain in hypogonadal men with chronic pain syndrome: A subanalysis of a prospective randomised controlled study in Japan (EARTH study). Andrologia 52 (9) (2020)
Hiroaki Iwamoto, Kouji Izumi, Atsushi Mizokami
Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis? International journal of molecular sciences 21 (23) (2020)
Hiroaki Iwamoto, Kouji Izumi, Takashi Shimada, Hiroshi Kano, Suguru Kadomoto, Tomoyuki Makino, Renato Naito, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami
Androgen receptor signaling-targeted therapy and taxane chemotherapy induce visceral metastasis in castration-resistant prostate cancer. The Prostate 81 (1) (2020)
Suguru Kadomoto, Kazuyoshi Shigehara, Hiroaki Iwamoto, Hiroshi Yaegashi, Kouji Izumi, Yoshifumi Kadono, Atsushi Mizokami
Testosterone Replacement Therapy for Patients with Hypogonadism after High Dose-Rate Brachytherapy for High-Risk Prostate Cancer: A Report of Six Cases and Literature Review. The world journal of men's health 38 (1) (2019)
Kouji Izumi, Atsushi Mizokami
Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells. Journal of clinical medicine 8 (3) (2019)
Hiroaki Iwamoto, Kouji Izumi, Ariunbold Natsagdorj, Renato Naito, Tomoyuki Makino, Suguru Kadomoto, Kaoru Hiratsuka, Kazuyoshi Shigehara, Yoshifumi Kadono, Kazutaka Narimoto, Yohei Saito, Kyoko Nakagawa-Goto, Atsushi Mizokami
Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells. The Prostate 79 (5) (2018)
Kenichiro Ishii, Takeshi Sasaki, Kazuhiro Iguchi, Shinya Kajiwara, Manabu Kato, Hideki Kanda, Yoshifumi Hirokawa, Kiminobu Arima, Atsushi Mizokami, Yoshiki Sugimura
Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation. The Prostate 78 (11) (2018)

Atsushi Mizokami.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Atsushi Mizokami